Evidence map›Paper›PMID 39175066›Full record

ArticleAddiction science & clinical practice2024

Introduction to the special series: using evidence to enhance health services for individuals using drugs in rural communities.

Erin L Winstanley, Sterling M McPherson, P Todd Korthuis

Abstract readEditorial
In one paragraph

Article in Addiction science & clinical practice, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Erin L WinstanleyDivision of General Internal Medicine, School of Medicine, University of Pittsburgh, 230 McKee Place, Pittsburgh, PA, 15213, USA. ELW194@pitt.edu.ORCID 0000-0003-3571-0259
Sterling M McPhersonElson S. Floyd College of Medicine, Washington State University, Spokane, WA, USA.ORCID 0000-0003-2551-4772
P Todd KorthuisOregon Health and Science University, Portland, OR, USA. elw194@pitt.edu.ORCID 0000-0001-5556-3597

Funding

Western States Node of the National Drug Abuse Treatment Clinical Trials Network (TMS for CUD) UG1DA015815 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Keith N. Humphreys, Philip Todd Korthuis · 2015 to 2026
$24.6M
Clinical Trials Network: Pacific Northwest Node (CTN-0082, -0131, -0139 and dissemination library)UG1DA013714 · NIDA · UNIVERSITY OF WASHINGTON · PI Mary Akiko Hatch, John M. Roll · 2015 to 2026
$19.8M
Project-008UG1DA049436 · NIDA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jane M. Liebschutz, Erin L Winstanley · 2019 to 2026
$10.5M
Oregon HIV/Hepatitis and Opioid Prevention and Engagement (OR-HOPE) Study Cost ExtensionUH3DA044831 · NIDA · OREGON HEALTH & SCIENCE UNIVERSITY · PI KORTHUIS, PHILIP TODD · 2019 to 2022
$4.0M
NIDA NIH HHS UG1 DA013714NIDA NIH HHS UG1 DA015815NIDA NIH HHS UG1 DA049436NIDA NIH HHS UH3 DA044831
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Substance-Related DisordersHumansRural Health ServicesRural Population

Identifiers

PMID39175066
PMCPMC11342497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.